Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2026-06-02 16:20:57 ET · period of report 2026-06-01 · accession 0002134322-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 16:20 | 2026-06-01 | MYGN | Jampa Raj | CTO | A - Grant | $0.00 | +251.9K | 251.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | A | A | 251,889 | $0.00 | 251,889 | D | — | — | (F1) Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. |